The Alaska Area Specimen Bank: a tribal–federal partnership to maintain and manage a resource for health research

References

• Heyward WL, Bender TR, Lanier AP, Francis DP, McMahon BJ, Maynard JE. Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos. Lancet. 1982; 2: 889–91.
   PubMed Web of Science ®Google Scholar
• Heyward WL, Lanier AP, Bender TR, McMahon BJ, Kilkenny S, Paprocki TR, etal. Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. Lancet. 1983; 2: 1161–2.
   Web of Science ®Google Scholar
• Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, etal. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol. 2000; 7: 885–8.
   Google Scholar
• Bruden D, McMahon B, Hennessy TW, Christensen CJ, Homan CE, Williams JL, etal. Estimating the date of hepatitis C virus (HCV) infection from patient interviews and antibody tests on stored sera. Am J Gastroenterology. 2004; 99: 1517–22.
   Web of Science ®Google Scholar
• Charo RA. Body of research-ownership and use of human tissue. N J Med. 2006; 355: 1517–9.
   Google Scholar
• Hakimian R, Korn D. Ownership and use of tissue specimens for research. JAMA. 2004; 292: 2500–4.
   PubMed Web of Science ®Google Scholar
• Catalona Washington University v. William J, Ward Washington University v. Richard N, etal. In the US Court of Appeals for the Eighth Circuit N. 06-2286 and 06-2301. 2006; December. 13
   Google Scholar
• Mello MM, Wolfe LE. The Havasupai Indian tribe case-lesson for research involving stored biologic samples. N J Med. 2010; 363: 204–7.
   Google Scholar
• Dalton R. Tribe blasts ‘exploitation’ of blood samples. Nature. 2002; 420: 111.
   Web of Science ®Google Scholar
• Kaufert J, Commanda L, Elis B, Grey R, Young KT, Masuzumi B. Evolving participation of aboriginal communities in health research ethics review: the impact of the Inuvik workshop. Int J Circumpolar Health. 1999; 58: 134–144.
   Google Scholar
• WHO. Indigenous peoples and participatory research. 2002. [cited 2012 May 5]. Available from: http://www.who.int/ethics/indigenous_peoples/en/index12.html.
   Google Scholar
• CIHR. guidelines for health research involving aboriginal people. 2011. [cited 2013 April 5]. Available from: http://www.cihr-irsc.gc.ca/e/29134.html.
   Google Scholar
• Sahota P. Research regulation in American Indian/Alaska native communities: a guide to reviewing research studies. 2007. [cited 2013 April 5]. Available from: http://www.ncaiprc.org/files/Research%20Regulation%20in%20AI%20AN%20Communities%20-%20Guide%20to%20Reviewing%20Research%20Studies.pdf.
   Google Scholar
• American Indian Law Center. Model tribal research code: with materials for tribal regulation for research and checklist for Indian Health Boards. 1999. [cited 2013 April 5]. Available from: http://www.nptao.arizona.edu/research/NPTAOResearchProtocolsWebPage/AILawCenterModelCode.pdf.
   Google Scholar
• Freeman WL. IHS guidelines for implementing and complying with IHS policy on specimens. 2001. [cited 2013 April 5]. Available from: http://www.aatchb.org/epi/docs/ResearchEthics/T3-Specimen.pdf.
   Google Scholar
• Lanier AP, Trujillo DE, Schantz PM, Wilson JF, Gottstein B, McMahon BJ. Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid. Am J Trop Med Hyg. 1987; 37: 609–15.
   PubMed Web of Science ®Google Scholar
• Walters LL, Tirrell SJ, Shope RE. Seroepidemiology of California and bunyamwera serogroup (bunyaviridae) virus infections in native populations of Alaska. Am J Trop Med Hyg. 1999; 60: 806–21.
   Web of Science ®Google Scholar
• McMahon BJ, Parkinson AJ. Clinical significance and management when antibody to hepatitis B core antigen is the sole marker of HBV infection. Viral Hepat Rev. 2000; 6: 229–39.
   Google Scholar
• Dentinger CM, McMahon BJ, Butler JC, Dunaway EE, Zanis C, Bulkow L, etal. Persistence of antibody and protection from disease among Alaska Natives immunized against hepatitis B beginning at birth. Pediatr Infect Dis J. 2005; 24: 786–92.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Rhoades ER, Heyward WL, Tower E, Ritter D, Lanier AP, etal. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaska Natives. Lancet. 1987; 2: 1134–6.
   Web of Science ®Google Scholar
• McMahon BJ, Schoenberg S, Bulkow L, Wainwright RB, Fitzgerald MA, Parkinson AJ, etal. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol. 1993; 138: 544–9.
   PubMed Web of Science ®Google Scholar
• McMahon B, Beller M, Williams J, Schloss M, Tantila H, Bulkow LR. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis vaccine. Arch Pediatr Adolesc Med. 1996; 150: 733–9.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, etal. Immunogenicity and protection of hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005; 142: 333–41.
   PubMed Web of Science ®Google Scholar
• Federal policy for the protection of human subjects (‘common rule’). 1991. [cited 2013 April 5]. Available from: http://www.hhs.gov/ohrp/humansubjects/commonrule/index.html.
   Google Scholar
• Information relating to Advanced Notice of Proposed Rulemaking (ANPRM) for revisions to the Common Rule. 2012. [cited 2013 April 5]. Available from: http://www.hhs.gov/ohrp/humansubjects/anprm2011page.html.
   Google Scholar